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Abstract
High-throughput RNA sequencing (RNA-seq) has emerged as a revo-
lutionary and powerful technology for expression profiling. Most proposed
methods for detecting differentially expressed (DE) genes from RNA-seq
are based on statistics that compare normalized read counts between
conditions. However, there are few methods considering the expression
measurement uncertainty into DE detection. Moreover, most methods
are only capable of detecting DE genes, and few methods are available for
detecting DE isoforms. In this paper, a Bayesian framework (BDSeq) is
proposed to detect DE genes and isoforms with consideration of expression
measurement uncertainty. This expression measurement uncertainty
provides useful information which can help to improve the performance
of DE detection. Three real RAN-seq data sets are used to evaluate the
performance of BDSeq and results show that the inclusion of expression
measurement uncertainty improves accuracy in detection of DE genes
and isoforms. Finally, we develop a GamSeq-BDSeq RNA-seq analysis
pipeline to facilitate users, which is freely available at the website
http://parnec.nuaa.edu.cn/liux/GSBD/GamSeq-BDSeq.html.
1 Introduction
In the past decades, DNA microarray is the most important and widely used
technology for gene expression measurement, but recently high-throughput
RNA sequencing (RNA-seq) has rapidly become a revolutionary and powerful
alternative for transcriptome analysis[1]. RNA-seq offers several advantages
over microarrays, such as an increased dynamic range, a lower background
level and a higher throughput. Moreover, RNA-seq enables many applications
not achievable by microarrays including discovering unknown transcripts and
alternative splicing[2, 3].
In transcriptome analysis, one fundamental objective is to detect differential
expression, i.e., genes and isoforms that show differential expression between
conditions[4]. RNA-seq sequences cDNA fragments that have been derived from
an RNA sample and hence produce millions or billions of short subsequence
called reads. These reads typically are mapped the a reference genome
sequence or the transcriptome sequences. The number of reads mapped
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to a genomic feature of interests, which can be a gene, an exon or any
region of interest, is used to quantify the abundance of the feature in the
analyzed sample[3]. Subsequently statistical methods are applied to detect
the differential expression between conditions[5]. The general workflow of
differential expression analysis is shown in Fig.1. Although RNA-seq has several
advantages over DNA microarrays, in reality the analysis of RNA-seq data still
remains some difficulties, some of which are inherent to sequencing procedure
of RNA-seq experiments, e.g., read mapping ambiguities and sequencing biases.
Therefore, detecting differential expression is still an important and key task in
transcriptome analysis[6].
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Figure 1: The general workflow of differential expression analysis for RNA-seq
data.
Recently, many statistical methods are proposed to detect differential
expression from RNA-seq data. Most of methods, named count-based methods,
are based on statistics that compare read counts between conditions[7]. The
read counts are generally normalized by the sequencing depths or library sizes
(the total number of mapped reads) for different samples[8]. Most count-based
methods commonly use the negative binomial(NB) distribution to address the
over-dispersion problem which is caused by the high variability across read
counts[9, 10, 11, 12, 13, 14, 15, 16]. In addition, Voom estimates the mean-
variance relationship and applies the normal linear model to fit read counts[17].
NPEBseq developes a novel nonparametric empirical Bayesian-based approach
to model RNA-seq data[18]. These methods are useful for detecting DE genes,
because the read counts can be exactly obtained for most genes. When DE
isoforms are of interest, researchers often apply the count-based methods directly
to estimate isoform counts[19]. However, sharing of exons between isoforms of
the same genes and sequence homology between genes can result in the read
mapping ambiguity. As a result, reads may be aligned to multiple transcripts
in the same gene or different genes. Hence, it is difficult to exactly obtain the
read counts for each isoform. Therefore, it is not appropriate to use count-based
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methods for detection of DE isoforms.
Because of read mapping ambiguity, estimating isoform expression is a
difficult task. A distinct advantage of RNA-seq is that sequencing along splice
junctions facilitates estimating the isoform expression level. A number of
methods have been proposed to deal with the read mapping ambiguity and
estimate isoform expression level, such as rSeq[20], RSEM[21], Cufflinks[22]
and BitSeq[23]. Once isoform expression levels are obtained, accurately
detecting DE isoforms becomes in need. Some methods have been developed to
simultaneously detect DE genes and isoforms and typically are implemented in
two steps. The first step is to adopt expression estimation methods to obtain
gene and isoform expression. Then in the second step, the obtained expression
is used to detect differential expression. We name these methods as two-step
methods. For example, EBSeq suggests applying RSEM to quantify expression
level and then using an empirical Bayes model for identifying DE genes and
isoforms[24]. CuffDiff uses the expression levels obtained from Cufflinks and
implements a linear statistical model to evaluate the expression changes of
genes and isoforms[25]. BitSeq contains two serial steps, i.e., the expression
estimation and differential expression analysis. The required expression levels
for DE detection are calculated by the step of the expression estimation. Among
these approaches, some expression estimation methods, such as Cufflinks and
BitSeq, can simultaneously provide the expression level and the associated
measurement uncertainty, which accounts for the read mapping ambiguity
and sequencing biases. But EBSeq only uses expression levels and ignores
the associated measurement uncertainties. It has been testified that such
measurement uncertainty is important in DE detection and can lead to improved
analysis results in microarray analysis[26, 27, 28]. However, the measurement
uncertainty receives less attention in RNA-seq analysis. Although CuffDiff[25]
and BitSeq[23] can account for expression measurement uncertainty in DE
detection, CuffDiff often finds fewer DE genes and isoforms than comparable
methods[24], and BitSeq is too time-consuming due to the lowly-efficient Markov
Chain Monte Carlo calculations.
In our previous work, we have proposed the GamSeq model which is able
to estimate the expression level and the associated measurement uncertainty
at both gene and isoform levels[29]. In this contribution, because it has been
proven that the expression measurement uncertainty can lead to improved DE
analysis, we develop a Bayesian framework, BDSeq, to simultaneously detect
DE genes and isoforms with the consideration of the expression measurement
uncertainty, which can be obtained from GamSeq. The expression measurement
uncertainty can account for both the read mapping ambiguity and sequencing
biases. BDSeq adopts two different Bayesian models to integrate the expression
measurement uncertainty for DE detection, the basic model and the fast
model. Another advantage of BDSeq is that it combines technical or biological
replicate measurements when performing DE analysis and can be calculated
efficiently. We evaluate BDSeq on three real RAN-seq data sets and compare
it with other popular methods. Also, for users’ convenience, we develop a
GamSeq-BDSeq RNA-seq analysis pipeline. Users can easily apply GamSeq
to estimate expression level and then use BDSeq to detect DE genes and
isoforms. Meanwhile, the pipeline also provides a user-friendly interface to other
approaches.
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2 Methods
BDSeq simultaneously considers the expression level and the associated mea-
surement uncertainty, which can be obtained from GamSeq. Therefore, before
introducing BDSeq, we first provide a brief introduction to GamSeq.
2.1 Expression level estimation
GamSeq adopts a Gamma-based model to simulate the generation process
of read data. With the adoption of known annotation, GamSeq is able to
estimate gene and isoform expression level and the associated measurement
uncertainty. This model can deal with the read mapping ambiguity and
non-uniform read distribution, which are the major challenging problems for
expression estimation.
For each gene, we first design pseudo-probes similar to probes in microarray,
and then count the number of reads falling into each pseudo-probe. The
parameter yjl represents the read count of j-th pseudo-probe in the l-th lane.
The lane can be deemed as a replicate. We assume yjl =
∑
k sjlk, where
yjl is normalized by the sequencing depth of the l-th lane and sjlk is the
count contributions from the k-th isoform. We assume sjlk follows a Gamma
distribution, sjlk ∼ Gamma(αlk, bj), where the parameter αlk is a quantity
proportional to the abundance of the k-th isoform for l-th lane and bj is the
sequencing preference of the j-th pseudo-probe. The bj is shared across all
lanes and follows a Gamma distribution, bj ∼ Gamma(c, d). Under these
assumptions, yjl also follows a Gamma distribution,
yjl ∼ Gamma(
∑
k
Mjkαlk, bj), (1)
whereMjk is defined as the indicator function Mjk = 1 if the j-th pseudo-probe
belongs to the k-th isoform, otherwise, Mjk = 0.
The log-likelihood of the observed read counts for a specific gene is
L({yjl}|{αlk}, c, d) = ln
∏
j
∏
l
P (yjl)
=
∑
j
ln
∫
dbjP (bj |c, d)
∏
l
P (yjl|
∑
k
Mjkαlk, bj).
(2)
The parameters can be estimated using maximum likelihood estimation.
Until all parameters reach stable values, we can use these parameters to infer
the expression levels and the associated measurement uncertainties of genes
and isoforms. For detailed information of GamSeq, please read the original
paper[29].
2.2 Differentially expression analysis
2.2.1 The basic model
We consider a full Bayesian method for combination of replicated expression.
For each gene, a Gaussian distribution of logged expression level across replicates
is assumed by
xˆjl ∼ N (µj , λ
−1 + σ2ij), (3)
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where i is the index of replicate and j is index of condition. The parameter µj
is the mean logged expression level under condition j and λ is the inverse of the
between-replicate variance. We take the expression measurement uncertainty
σ2ij into consideration, which is can be obtained from GamSeq. We make a
prior assumption that µj and λ
−1 are independent and assume µj follows a
Gaussian prior, µj ∼ N (µ0, δ
−1
0 ), where µ0 and δ0 are hyper-parameters, on
which we adopt noninformative hyperpriors. We assume λ follows a conjugate
Gamma prior, λ ∼ Ga(α, β).
The basic model is abbreviated to BDSeqB and the probabilistic graphical
model is shown in the left subplot in Fig.2. BDSeqB includes the latent
parameters h = {{µj}, λ} and the hyper-parameters θ = {µ0, δ0, α, β}.
The log-likelihood L(θ, h) of the observed data D, can be written by the
following function,
L(θ, h) = logP (D|h) = log
∫
dhP (D|θ, h)P (h|θ). (4)
However, this integral is intractable. We use a distribution Q(h) over h and
Jensen’s inequality to get a lower bound of L(θ, h). We use the EM algorithm
combined with a variational method to optimize the lower bound of L(θ, h) and
work out the hyper-parameters in M-step[30]. We assume that the µj and λ are
independent and obtain the optimization of Q(µj) and Q(λ) in E-step:
Q(µj) ∝ N (µj ;
∑
i〈sij〉xˆij + µ
t
0δ
t
0∑
i〈sij〉+ δ
t
0
, (
∑
i
〈sij〉+ δ
t
0)
−1), (5)
Q(µj) ∝ NGa(λ;α
t, βt)
∏
ij
Ga(sij ;
3
2
,
1
2
〈(xˆij − µj)
2〉), (6)
where sij = (λ
−1 + σ2ij)
−1 and 〈∗〉 represents the expectation of a function
with respect to Q(µj) or Q(λ). Since Q(λ) is not a standard distribution, the
expectation of Q(λ) cannot be directly obtained. Importance sampling is thus
used to calculate the expectation of Q(λ). When the whole EM algorithm is
converged, Q(µj) we need in Eq.(5) is the approximated posterior distribution
of mean expression level of condition j.
2.2.2 The fast model
In the Basic model (BDSeqB), we use important sampling procedure to calculate
the expectation of Q(λ). As the number of replicates increases, the distribution
of Q(λ) become more and more flat. Important sampling procedure needs more
samples to approximate the expectation of Q(λ). This results in low computing
efficiency.
In order to avoid the important sampling procedure, we modify the BDSeqB
and add a new hidden variable xij , which represents the true expression for
each gene on each replicates[31]. The new model is called BDSeqF, and the
probabilistic graphical model is shown in the right subplot in Fig.2. We assume
the hidden variable xij is Gaussian distributed,
xij ∼ N (µj , λ
−1), (7)
5
LC
α
C
L
α
Figure 2: The probabilistic graphical models of BDSeqB(left) and BD-
SeqF(right). The black solid circles represent the observed data and the blank
circles represent the hidden parameters. The solid dots represent the hyper-
parameters. C is the number of conditions and L is the number of the replicates
under one condition.
where µj and λ
(−1) has the same prior assumptions as in BDSeqB. Therefore,
the observed expression level can be expressed as:
xˆij ∼ N (xij , σ
2
ij), (8)
The new hierarchical model includes the latent parameters h = {{µj}, {xij}, λ}
and the hyper-parameters θ = {µ0, δ0, α, β}.
Similar to BDSeqB, EM algorithm combined with a variational method is
used to optimize the lower bound of Eq.(4). The parameters are assumed to be
independent of each other. At E-step, the distributions of Q(xij), Q(µj) and
Q(λ) are all standard distributions as,
Q(xij) ∝ N (xij ;
xˆij + σ
2
ij〈µj〉〈λ〉
1 + σ2ij〈λ〉
,
σ2ij
1 + σ2ij〈λ〉
), (9)
Q(µj) ∝ N (µj ;
〈λ〉
∑
i xij + µ
t
0δ
t
0
δt0 +
∑
i〈λ〉
, (δt0 +
∑
i
〈λ〉)−1), (10)
Q(λ) ∝ Ga(λ;αt +
∑
ij
1
2
, βt +
∑
ij
1
2
〈(xˆij − µj)
2〉). (11)
Therefore expectation of them can be quickly obtained in the EM algorithm.
BDSeqF avoids the important sampling procedure and can improve the
computation efficiency.
2.2.3 Testing for differential expression
Once the distribution of Q(µj) is obtained, the posterior distribution P (µj |D, θ)
can be calculated and used to test the DE genes or isoforms between any two
conditions. For instance, there are two conditions (indicated by c1 and c2) and
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the expression c1 is supposed to be greater than expression c2, then we can
compute the probability of expression level by
P (µc1 > µc2|D, θ) =
∫ +∞
0
d(µc1 > µc2)P (µc1 > µc2|D, θ), (12)
which we refer to as the Probability of Positive Log-Ratio (PPLR). The obtained
PPLR values are judged by a level of confidence, like α-level in the conventional
statistical test. Subsequently, ordering DE gene or isoforms based on the PPLR
values produces a ranking of most probable up-regulated and down-regulated
genes or isoforms. The similar test has previously been used for the analysis of
RNA-seq[23] and microarray data[27, 28].
2.2.4 The BDSeq framework
Although the BDSeq framework contains two models: BDSeqB and BDSeqF,
the processing flow of BDSeq framework is mainly divided into two procedures:
• Estimation: Combined with the expression level and the associated mea-
surement uncertainty for each replicate, BDSeq estimates the expression
level and standard deviation of each condition.
• Evaluation: Using the results of above outputs, BDSeq adopts the PPLR
value to test the differential expression.
The BDSeq framework is listed in Algorithm 1.
Algorithm 1 : BDSeq
Input: Observed data D, Condition C.
Estimation:
repeat
E-step:
Q(h)t+1 = P (h|θt,D).
for BDSeqB: Q(h) = Q(µ)Q(λ).
for BDSeqF: Q(h) = Q(X)Q(µ)Q(λ).
M-step:
θt+1 = argmaxθ
∫
dhQ(h)t+1 logP (D|h, θ)P (h|θ).
until EM algorithm converges.
Evaluation:
Calculate P (µc1 > µc2|D, θ).
Output: A PPLR value.
From the Algorithm 1, the major difference of BDSeqB and BDSeqF is
E-step. And this results in a distinct complexity between two models. The
detailed discussion about complexity analysis and selection of two models is
given in Section 3.6. In this paper, BDSeq mentioned means that BDSeqB and
BDSeqF are simultaneously applied.
The BDSeq framework is implemented as an R package. The R package and
documentation are freely available at the website http://parnec.nuaa.edu.cn/liux/GSBD/GamSeq-BDSeq.html.
2.3 The GamSeq-BDSeq analysis pipeline
BDSeq requires calculated gene and isoform expression and the associated
measurement uncertainty, but is not limited to any particular expression
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estimation methods. For users’ convenience, we develop a GamSeq-BDSeq
analysis pipeline, so that users can easily apply GamSeq to estimate expression
level and then apply BDSeq to detect DE genes and isoforms. Meanwhile, the
pipeline can also provide the read counts of each gene for count-based methods.
The flow diagram of GamSeq-BDSeq analysis pipeline is shown in Fig.3.
A
B
C
Alignments
PreprocessingAnnotation
GamSeq
BDSeq
Figure 3: The flow diagram of the GamSeq-BDSeq analysis pipeline.
In general, RNA-seq analysis pipeline firstly aligns reads to the reference
sequence. Then the alignments are preprocessed according to annotation files
to obtain read counts of genes and the mapping relationship between genes and
isoforms. The GamSeq-BDSeq analysis pipeline mainly contains the following
three routes.
• Route A: Users apply GamSeq to estimate the gene and isoform
expression level and the associated measurement uncertainties, and then
use BDSeq to detect DE genes and isoforms. In this paper, BDSeq employs
this route to detect differential expression.
• Route B: After preprocessing, read counts can be obtained for each gene.
Count-based methods can use the counts to detect DE genes. In the
following analysis, count-based methods, such as [11, 12, 13, 14, 15], all
adopt this route to detect DE genes.
• Route C: The input of BDSeq is not specific to expression estimation from
any particular expression estimation method. Any expression estimation
method, which is able to provide the expression level and the associated
measurement uncertainty, can be used by BDSeq to detect DE genes and
isoforms.
For detailed usage of GamSeq-BDSeq analysis pipeline, please refer to
the documentation of the pipeline, which is freely available at our website,
http://parnec.nuaa.edu.cn/liux/GSBD/GamSeq-BDSeq.html.
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3 Results and Discussion
3.1 Data sets
In order to evaluate the performance of BDSeq, we use three real RNA-seq data
sets. Two are used to detect DE genes, and one is utilized to detect DE isoforms.
We select a real RNA-seq data set from Microarray Quality Control (MAQC)
project to evaluate BDSeq for detecting DE genes. The MAQC project
compared the multiple whole-genome gene expression profile across various
commercial platforms at an unprecedented scale, and is wildly used in evaluating
platform performance and testing for various data processing approaches[32].
The selected data set (SRA010153) contains two conditions, one from brain
tissue (HBR) and the other from a mixture of brain tissue type (UHR). Each
condition has seven lanes which can be deemed as seven technical replicates.
In the MAQC project, about 1000 genes are validated by the TaqMan qRT-
PCR experiment and can be served as ground truth to evaluate the DE analysis
methods. We adopt the same strategy in [33] to filter out 305 genes including
217 DE genes and 88 non-DE genes with high confidence according to qRT-
PCR measurements. These 305 genes are used as a ”gold standard” to compare
methods.
A real human colorectal cancer data set (Griffith) is also used to further
evaluate BDSeq for detecting DE genes. The Griffith data set compared
fluorouracil (5-FU)-resistant human colorectal cancer cell lines MIP101 against
their non-resistant counterpart MIP/5-FU24[34]. Each condition has seven lanes
which can be taken as technical replicates. There are 192 genes which are
assayed by qRT-PCR. We used 20 DE genes and 14 non-DE genes with high
confidence as the ”gold standard” to compare different DE methods.
A real human breast cancer data set (HBC) is used to evaluate BDSeq
for detecting DE isoforms[35]. This data set includes two condition, human
breast cancer cell line (MCF-7) and normal cell line (HME), which have seven
and four lanes respectively. Eight isoforms in four genes (TRAP1, ZNF580/1,
HIST1H2BD and WISP2) have been validated using qRT-PCR experiment on
the same cell lines. We compare different DE methods with the log2 fold change
results of DE isoforms based on this qRT-PCR validated data.
3.2 Accounting for expression measurement uncertainty
One of the major advantages of BDSeq is accounting for expression measurement
uncertainty in DE analysis. We make use of MAQC data set to show the
usefulness of expression measurement uncertainty in BDSeq.
Fig.4 shows that the expression measurement uncertainty is useful for DE
analysis in BDSeq. By considering measurement uncertainty, we obtain better
ROC curves for both two models than ignoring measurement uncertainty. The
area under ROC curve (AUC) for BDSeqB is 0.9207 if ignoring measurement
uncertainty, while 0.9601 if accounting for measurement uncertainty. For
BDSeqF, the AUC values for considering and ignoring measurement uncertainty
are 0.9472 and 0.9054, respectively. The results demonstrate that accounting
for expression measurement uncertainty can significantly improve the accuracy
in DE analysis.
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Figure 4: Usefulness of expression measurement uncertainty for BDSeq. The
left figure is the performance of BDSeqB and the right figure is the performance
of BDSeqF. The ROC curves indicate the difference between accounting for
and ignoring measurement uncertainty in DE analysis. The solid curve shows
the performance of BDSeq accounting for measurement uncertainty, and the
dash curve ignores the uncertainty by setting zero measurement uncertainty in
BDSeq.
3.3 Detecting DE genes with qRT-PCR validation
In this paper, we mainly focus on two-step methods which are able to
simultaneously detect DE genes and isoforms. Therefore, BDSeq is compared
with EBSeq(v.1.1), CuffDiff(v.2.0.2) and BitSeq(v0.4.2). Meanwhile, we
also compare BDSeq with two count-based methods, DESeq(v1.8.3) and
BaySeq(v1.10.0), to identify DE genes. The input read counts of each gene
of the two count-based methods are obtained from Route B in GamSeq-BDSeq
analysis pipeline and are normalized by library sizes. EBSeq and CuffDiff use
the gene expression levels via RSEM(v.1.2.4) and Cufflinks(v.2.0.2) respectively.
BitSeq software includes two stages, the expression estimation and differential
expression analysis, and the required gene expression levels are processed
through the expression estimation stage. BDSeq makes use of Route A in
GamSeq-BDSeq analysis pipeline.
We use the MAQC data set to evaluate the performance of BDSeq. The
MAQC data set contains 305 validated qRT-PCR genes, which are deemed as
”gold standard”. Fig.5 shows the partition of these qRT-PCR validated genes.
305 genes are divided into three groups, with ”low”, ”medium” and ”high”
expression respectively, to evaluate the performance of DE methods for genes
with different expression levels. The group of all genes is denoted as ”all”.
For each gene group, we plot ROC curves individually with eight differential
expression analysis methods as shown in Fig.6. The corresponding AUC values
are shown in Table 1. In the ”all” group, we can see that BDSeqB and BDSeqF
obviously outperform the three two-step methods. Compared with count-based
methods, BDSeqB and BDSeqF outperform BaySeq, and are slightly worse than
DESeq. For the ”high” and ”medium” groups, results of BDSeqB and BDSeqF
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Figure 5: The partition of qRT-PCR validated genes in MAQC data set. The
scatter plot is drawn using qRT-PCR measurement values of HBR sample
against UHR sample. Two lines, y = −x − 6 and y = −x − 3, divide the
305 genes into 3 groups, labelled as ”low”, ”medium” and ”high”.
are still better than the three two-step methods, and are competitive compared
with the count-based methods. However, BDSeqB and BDSeqF both fail in the
”low” group. The reason is that there is usually a high level of noise contained
in low expression data and most expression estimation methods cannot output
accurate expression for low expression genes. In general, BDSeq obtains the
most accurate result among the two-step methods for all genes.
Table 1: Area under ROC curves from different methods for MAQC and Griffith
data set
DESeq BaySeq BitSeq CuffDiff EBSeq BDSeqB BDSeqF
MAQC
Low 0.9362 0.9056 0.8533 0.8256 0.9235 0.8726 0.8552
Medium 0.9921 0.9714 0.9348 0.8790 0.8200 0.9872 0.9565
High 0.9989 0.9426 0.8404 0.9658 0.8936 1.0000 1.0000
All 0.9677 0.9375 0.8509 0.8593 0.8703 0.9601 0.9472
Griffith All 0.8143 0.6179 0.5539 0.5571 0.7161 0.8107 0.7535
The highest AUC value is highlighted for each group.
Next, we use the Griffith data set to further evaluate the performance
of BDSeq. The Griffith data set contains 34 genes validated by qRT-PCR
experiments and these 34 genes are deemed as ”gold standard” with high
confidence. We plot ROC curves for seven methods as shown in Fig.7, and
the corresponding AUC values are shown in Table 1. We can see that DESeq,
BDSeqB and BDSeqF obtain the top three results for Griffith data. When false
positive rate is below 0.2, BDSeqB and BDSeqF have significantly higher true
positive rate than the other five methods, showing the best sensitivity of BDSeq
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Figure 6: ROC curves from different methods for MAQC data set. ROC
curves are calculated from eight methods for ”all”, ”low”, ”medium” and ”high”
groups. The false positive rate of ROC curves is below 0.4 for focusing on the
most significant DE genes.
among these competitors.
Figure 7: ROC curves from different methods for Griffith data set.
We have used MAQC and Griffith data sets to evaluate the seven methods
in detecting DE genes. From these results, we find that BDSeqB and BDSeqF
outperform the two-step methods and also have the competitive performance
against the count-based methods. The count-based methods, such as DESeq
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and BaySeq, generally have better performance than CuffDiff and BitSeq, but
have the disability of detecting DE isoforms. In addition to the detection of
DE genes, CuffDiff, BitSeq and BDSeq are also able to detect DE isoforms.
Therefore, these approaches have broader application in transcriptome analysis.
3.4 Detecting DE isoforms with qRT-PCR validation
Because the count-based methods are not able to detect DE isoforms, BDSeq is
compared with EBSeq, CuffDiff and BitSeq to detect DE isoforms.
We use the HBC data set to evaluate the performance of BDSeq in detecting
DE isoforms. The HBC data set contains two conditions, HME and MCF-7.
Eight isoforms are validated by qRT-PCR and considered as ”gold standard”.
From the column of qRT-PCR in Table 2, eight isoforms are all up-regulated
DE isoforms, which means that expression levels of these isoforms in MCF-7 cell
lines are greater than those in HME cell line. The results of the eight isoforms
from various methods are shown in Table 2. We note that all methods except
CuffDiff successfully detect seven DE isoforms. For BDSeqB and BDSeqF,
the PPLR values of seven consistent isoforms all equal to 1. This means
that the seven isoforms are considered as the most significantly DE. Only the
results of ”uc002cvs.1” isoform are not consistent with qRT-PCR results for all
methods. Because the log2 fold change of ”uc002cvs.1” obtained from qRT-PCR
measurements is 0.5, this isoform is weakly up-regulated, and is thus difficult
to be detected. Noteworthily, CuffDiff fails to identify all eight DE isoforms
showing the lowest power in DE detection among these methods.
Table 2: Results of isoforms between two conditions in HBC data set
qRT-PCR EBSeq CuffDiff BitSeq BDSeqB BDSeqF
uc002cvt.2 DE+ S(0.0001) N(0.9999) S(0.9993) S(1.0000) S(1.0000)
uc002cvs.1 DE+ N(0.4764) N(1.0000) N(0.8400) N(0.5928) N(0.5706)
uc002qlq.1 DE+ S(0.0001) N(0.9999) S(0.9994) S(1.0000) S(1.0000)
uc002qlp.1 DE+ S(0.0001) N(0.9999) S(0.9881) S(1.0000) S(1.0000)
uc002xmn.1 DE+ S(0.0359) N(1.0000) S(1.0000) S(1.0000) S(1.0000)
uc002xmo.1 DE+ S(0.0000) N(0.8511) S(1.0000) S(1.0000) S(1.0000)
uc003ngr.1 DE+ S(0.0000) N(0.2438) S(1.0000) S(1.0000) S(1.0000)
uc003ngs.1 DE+ S(0.0000) N(0.6421) S(1.0000) S(1.0000) S(1.0000)
The ”DE+” represents that the isoform is up-regulated and expression level of the isoform
in MCF-7 cell line is greater than that in HME cell line. ”S” represents the isoform is
significantly DE isoform and the direction of expression change is consistent with qRT-PCR
measurement. ”N” represents the isoform is non-DE isoform and the direction of expression
change is not consistent with qRT-PCR measurement. The values in brackets for various
methods are used to detect DE isoforms. CuffDiff uses false discovery rate (FDR) whereas
EBSeq applies posterior probabilities. BitSeq, BDSeqB and BDSeqF all use PPLR values.
When the value of CuffDiff or EBSeq is less than 0.05, the corresponding isoform is deemed
as significantly DE. In contrast, PPLR value is greater than 0.95, the corresponding isoform
is deemed as significantly DE.
In the real world, due to the lack of isoforms validated by qRT-PCR
experiments, we build additional eight comparisons to further evaluate the
performance of BDSeq in DE detection. Each comparison consists of two
isoforms within a gene under the same condition. We detect differential
expression of the two isoforms and compare the regulation relationship of the
two isoforms with qRT-PCR results. According to qRT-PCR measurements,
eight comparisons are all DE, and contain four up-regulations and four down-
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regulations. Because the programs of CuffDiff, EBSeq and BitSeq are not able to
deal with these types of comparisons, we choose a baseline comparable approach,
t-test, to detect DE comparisons. Since BitSeq obtains the best results among
the above three methods in Table 2, the input values of t-test are expression
levels estimated by BitSeq. Then we compare BDSeq and t-test with qRT-PCR
results and show the comparison results in Table 3. We note that BDSeqB and
BDSeqF can detect four and five consistent comparisons respectively, but t-test
detects only two consistent comparisons. BDSeq is obviously better than the
baseline comparable approach, t-test.
In a word, for detecting DE isoforms between two conditions, BDSeqB and
BDSeqF obtain accurate results as well as EBSeq and BitSeq, and are obviously
better than CuffDiff. Furthermore, for detecting DE comparisons, our method
is also clearly better than the baseline approach, t-test.
Table 3: Results of comparisons in HBC data set
Gene Comparisons Condition qRT-PCR t-test BDSeqB BDSeqF
TRAP1 uc002cvt.2 vs uc002cvs.1
HME DE+ N(0.0000) N(0.4927) N(0.4940)
MCF-7 DE+ N(0.0000) N(0.0030) N(0.0000)
ZNF580/1 uc002qlq.1 vs uc002qlp.1
HME DE- S(0.0000) S(0.0301) S(0.0063)
MCF-7 DE- S(0.0000) S(0.0000) S(0.0000)
WISP2 uc002xmn.1 vs uc002xmo.1
HME DE- N(0.3991) N(0.9997) N(1.0000)
MCF-7 DE- N(0.0801) N(0.0790) S(0.0410)
HIST1H2BD uc003ngr.1 vs uc003ngs.1
HME DE+ N(0.0025) S(1.0000) S(1.0000)
MCF-7 DE+ N(0.0002) S(1.0000) S(1.0000)
The ”DE+” represents that the expression of second isoform is greater than that of the
first isoform within a gene, otherwise, ”DE-”. ”S” represents the comparison is significantly
DE and the direction of expression change is consistent with qRT-PCR measurement. ”N”
represents the comparison is non-DE and the direction of expression change is not consistent
with qRT-PCR measurement. The values in brackets for various methods are used to
detect DE comparisons. t-test uses p-values and BDSeq uses PPLR values. When PPLR
value is greater than 0.95, the corresponding comparison is deemed as significantly ”DE+”.
In contrast, PPLR value is less than 0.05, the corresponding comparison is deemed as
significantly ”DE-”. For t-test, when p-value is less than 0.05, the corresponding comparison
is deemed as significantly ”DE+” with the positive log2 fold change of expression levels,
whereas the corresponding comparison is deemed as significantly ”DE-” with the negative
log2 fold change of expression levels.
3.5 Detecting DE genes and isoforms without qRT-PCR
validation
We further analysis the Griffith data set to evaluate our method on all genes
and isoforms without qRT-PCR validation. After filtering out genes for which
total counts over all replicates are less than 10, the data set contains 17041
genes and 101163 isoforms. We use six and three methods to detect DE genes
and isoforms, respectively. When PPLR values are less than 0.05 or greater
than 0.95, the genes or isoforms are deemed as significantly DE for BitSeq and
BDSeq. For other methods all genes or isoforms are found to be significantly
DE at a threshold of 0.05.
First, we analyze the performance of various methods at the gene level.
In Fig.8, the top panel shows the number of genes which are found to be
significantly DE between the two conditions. The highest number of DE genes is
found by BDSeqF, while CuffDiff returns the least. Next, we study the overlap
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between the sets of genes called DE by various methods. We select two typical
methods, DESeq and BitSeq, to compare with BDSeq. The results are displayed
by two Venn diagrams in the lower panel of Fig.8. From the two Venn diagrams,
we note DE genes found by DESeq and BitSeq are to be at a large extent similar
to those detected by BDSeqB and BDSeqF. Meanwhile, BDSeqF can detect a
fair amount of ”unique” DE genes, which are not found by the other methods.
Figure 8: Analysis of Griffith data set at the gene level. The panel (top) shows
the number of DE genes found between two conditions by various methods.
The two Venn diagrams (bottom) show the numbers of DE genes identified by
BDSeqB, BDSeqF compared with DESeq and BitSeq, respectively.
We also evaluate the performance of various methods at the isoform level.
The top plot in Fig.9 shows the number of DE isoforms which are found between
the two conditions. We note that the number of DE isoforms found by BDSeqB
and BDSeqF is several times greater than that of EBSeq and BitSeq, while
CuffDiff still returns the least number of DE isoforms. In the real world, one
or several DE isoforms generally result in the corresponding DE genes between
conditions. About 5000 genes are considered as significantly DE from Fig.8 and
the average number of isoforms for a gene is 5.94. Hence EBSeq, BitSeq and
CuffDiff are too strict to control the number of DE isoforms and lose some DE
isoforms, especially CuffDiff. From the two Venn diagrams in Fig.9, we note
that at least half of DE isoforms found by EBSeq and BitSeq are also detected
by BDSeqB and BDSeqF.
From the comparisons above, we find that BDSeq has more power to obtain
more significantly DE genes and isoforms, especially DE isoforms. Noteworthily,
CuffDiff finds the fewest DE genes and isoforms among all methods. This
validates the drawback of CuffDiff which often finds fewer DE genes and isoforms
as mentioned in Leng et al.[24].
3.6 Model selection
From the above comparisons, BDSeqB and BDSeqF produce the similar
performance in detecting DE genes and isoforms. However, due to the adoption
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Figure 9: Analysis of Griffith data set at the isoform level. The panel (top)
shows the number of DE isoforms found between two conditions by various
methods. The two Venn diagrams (bottom) show the numbers of DE isoforms
identified by BDSeqB, BDSeqF compared with BitSeq and EBSeq, respectively.
of important sampling to approximate the posterior distribution, BDSeqB
involves in low efficiency of computation. In order to improve the computational
efficiency, BDSeqF are proposed to avoid the inefficient important sampling
procedure. We compare BDSeqF with BDSeqB in terms of computational
efficiency on Griffith data set. Computation time for the two models is shown
in Table 4. We note that BDSeqF is at least four times faster than BDSeqB. As
the number of replicates increases, the improvement of computational efficiency
for BDSeqF is more obvious compared with BDSeqB.
Table 4: The computation time (in minutes) of BDSeqB and BDSeqF
Replicates No. Replicates=6 Replicates=10 Replicates=14
BDSeqB(gene) 53.4 68.3 88.5
BDSeqF(gene) 12.1 12.8 15.3
BDSeqB(isoform) 469.8 502.8 647.9
BDSeqF(isoform) 99.3 104.7 116.3
Computation time is obtained on a 3.2GHz Quad-Core Intel machine with 16G RAM. After
filtering out genes for which total counts over all replicates are less than 10, the Griffith data
set contains 17041 genes and 101163 isoforms.
BDSeqB obtains relatively more accurate results than BDSeqF whereas
BDSeqF runs more quickly. In practice, the tradeoff between accuracy and
computational efficiency is necessary. When users only concern limited number
of known genes and isoforms, we recommend using BDSeqB to obtain more
accurate results. If users concern the differential expression of genes or isoforms
in the whole genome, we recommend choosing BDSeqF for quicker computation
and filter out a reduced number of features for further study.
For the workflow of differential expression analysis, different strategies result
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in the distinct computational efficiency. Count-based methods directly utilize
the normalized read counts between conditions. However, two-step methods
require to calculate the expression level before detecting DE. The consideration
of the various biases and the calculation of isoform expression levels make
these methods complex and more time-consuming compared against count-
based methods. In practice, users may choose appropriate methods according
to the purpose of their experiments. When users only concern DE genes, we
recommend using the count-based methods. If DE isoforms are of interest, the
two-step methods can be a proper solution.
4 Conclusion
In this paper, we have proposed a Bayesian framework, BDSeq, which combines
technical or biological replicates and considers the expression measurement
uncertainty to improve DE analysis. Unlike the popular count-based methods,
BDSeq is able to detect not only DE genes but also DE isoforms. It considers the
expression measurement uncertainty and makes full use of information in RNA-
seq data. The results from MAQC data set have proven that accounting for the
expression measurement uncertainty can significantly improve the accuracy of
DE analysis. For detecting DE genes, the results from MAQC and Griffith data
sets have shown that BDSeq outperforms the two-step methods and also has a
competitive performance against the count-based methods. For detecting DE
isoforms, BDSeq can obtain competitive results as the two-step methods, EBSeq
and BitSeq, and is obviously better than CuffDiff, which is the most popular
method for detecting DE isoforms. Meanwhile, we found that BDSeq has more
power to find more significantly DE genes and isoforms in the whole genome,
especially DE isoforms. Therefore, BDSeq accounts for expression measurement
uncertainty and improves the accuracy of DE analysis.
BDSeq framework adopts two different Bayesian models to integrate the
expression measurement uncertainty for DE detection. BDSeqB obtains
more accurate results than BDSeqF. However, BDSeqF obviously improves
computational efficiency compared to BDSeqB. Therefore, balance between the
accuracy and computational efficiency is in need in practice.
In order to facilitate users, we develop a GamSeq-BDSeq RNA-seq analysis
pipeline. In this pipeline, users can easily apply GamSeq to estimate the
expression level and the associated measurement uncertainty, and then use
BDSeq to detect DE genes and isoforms. Meanwhile, the pipeline also provides
a user-friendly interface for other approaches. It can produce the read counts of
each gene for count-based methods, and can process expression estimation from
other expression estimation methods, which are able to calculate the expression
level and the associated measurement uncertainty, for DE analysis.
All the above mentioned methods, including BDSeq, only detect differential
expression for a single gene. However, in the real world, biological phenomena
usually occur through the interactions of multiple genes via signalling pathways,
networks, or other functional relationships. Based on the prior biological
knowledge, a number of genes with related functions are grouped together and
referred to as a ”gene set”. Therefore, detecting the differential gene sets using
RNA-seq data can provide more useful information to biologists, and is likely
lead to more comprehensive biological conclusions.
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